Table 3 Flow chart of inclusion and follow-up visits
Procedure/data collection | Baseline (visit 1) | Follow-up (visit 2–4) | End of study (visit 5) |
|---|---|---|---|
Evaluation incl/excl criteria | X | ||
Informed consent | X | ||
Demography | X | ||
Medical history | X | ||
Family history | X | ||
New diagnoses | X | X | |
Health changes | X | X | |
Life-style factors | X | X | x |
Concomitant medications | X | X | X |
Clinical work-up | X | X | X |
HE-assessment (ANT) | X | X | X |
QoL questionnaires | X | X | X |
Muscle function test | X | X | X |
FibroScan | X | X | X |
Blood panels | X | X | |
Blood samples for research | X | X | |
MR-examination | X | X |